We are delighted to welcome Linda Alskär as a new consultant within Pharmaceutical Development and CMC.
Linda’s interest in pharmaceutical development began during her pharmacy studies at Uppsala University and led to doctoral research in Molecular Pharmaceutics, focusing on lipid-based drug delivery systems.
She brings broad experience across multiple therapeutic areas, drug products, and routes of administration. Her expertise includes formulation development of nasal products, vaccines, lipid-based formulations, and lipid nanoparticles, combined with experience in analytical methods, quality control, and product development.
Linda is particularly motivated by developing robust CMC strategies and applying Quality by Design principles to build quality into products throughout development. She enjoys solving complex challenges and helping teams and clients move projects forward through scientific expertise and collaboration.
As a colleague in the CMC team, Bengt Hedin is especially pleased to welcome Linda. Her expertise, positive energy, and collaborative mindset make her a valuable addition to both the team and our clients.
